Erasca to Present at the Guggenheim Securities SMID Cap Biotech Conference
SAN DIEGO, Jan. 31, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with ...
Targeted Oncology1 天
Exploring Zoldonrasib, Pan-RAS Inhibitors, and Future KRAS Therapies
Alexander I. Spira, MD, PhD, FACP, discusses the next steps in the clinical development of zoldonrasib for patients with KRAS ...
Zawya1 天
Ras Al Khaimah Chamber explores entrepreneurship cooperation with the Republic of Estonia
Al Nuaimi answered the questions and inquiries of H. E the Ambassador on the mechanism of supporting trade and investment ...
Verastem Oncology to Present at the Guggenheim SMID Cap Biotech Conference
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...
Erasca: Future 'Streamlined' But Still Uncertain
Erasca is a biotech company focused on developing therapies for RAS/MAPK pathway-driven cancers with a strong financial ...
Erasca's Naporafenib Is Shaping Up Nicely For NRASm Melanoma
Naporafenib is Erasca’s main candidate, and it has Fast Track status for NRASm melanoma. See why I rate ERAS stock as a buy.
Apparent vandalism cut electricity to some Monroe Street Bridge lights
The Monroe Street Bridge will be a little darker at night until next week after it appeared a vandal tampered with electrical ...
WHYY6 天
Newark, N.J. mayor condemns ICE raid on local fish market, calls it unconstitutional
Newark, N.J. Mayor Ras Baraka says there can be disagreements about immigrants, but everyone must respect and follow the U.S.